| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 12 | 2009 | 90 | 1.540 |
Why?
|
| Integrin alpha4beta1 | 9 | 2018 | 26 | 1.070 |
Why?
|
| Integrin beta Chains | 4 | 2021 | 9 | 1.030 |
Why?
|
| Leukocytes | 2 | 2021 | 208 | 0.850 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 298 | 0.790 |
Why?
|
| Syk Kinase | 3 | 2021 | 17 | 0.770 |
Why?
|
| Cefsulodin | 1 | 2021 | 1 | 0.680 |
Why?
|
| Ceftazidime | 1 | 2021 | 47 | 0.640 |
Why?
|
| T-Lymphocytes | 13 | 2022 | 1712 | 0.540 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 150 | 0.480 |
Why?
|
| Cell Adhesion | 10 | 2013 | 308 | 0.440 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2014 | 8 | 0.430 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2014 | 9 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2003 | 224 | 0.420 |
Why?
|
| Lymphocyte Activation | 9 | 2010 | 630 | 0.410 |
Why?
|
| Myosin Light Chains | 2 | 2012 | 11 | 0.380 |
Why?
|
| Enzyme Precursors | 2 | 2002 | 22 | 0.370 |
Why?
|
| Antigens, CD | 6 | 2012 | 414 | 0.350 |
Why?
|
| Thy-1 Antigens | 1 | 2011 | 18 | 0.350 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 28 | 0.350 |
Why?
|
| Protein Binding | 9 | 2021 | 1666 | 0.340 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 6 | 2013 | 72 | 0.330 |
Why?
|
| Antibodies, Bispecific | 1 | 2011 | 48 | 0.330 |
Why?
|
| Hydrogels | 2 | 2022 | 91 | 0.330 |
Why?
|
| Stromal Cells | 1 | 2011 | 310 | 0.300 |
Why?
|
| Selectins | 2 | 2008 | 4 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 380 | 0.290 |
Why?
|
| Nanofibers | 2 | 2019 | 17 | 0.280 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2008 | 60 | 0.270 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1999 | 197 | 0.270 |
Why?
|
| Phosphoproteins | 4 | 2003 | 454 | 0.260 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 137 | 0.260 |
Why?
|
| Immunologic Memory | 2 | 1999 | 194 | 0.260 |
Why?
|
| Interleukin-2 | 5 | 1999 | 237 | 0.250 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2016 | 95 | 0.240 |
Why?
|
| CD3 Complex | 4 | 2000 | 93 | 0.240 |
Why?
|
| Hindlimb | 2 | 2016 | 72 | 0.240 |
Why?
|
| Models, Molecular | 3 | 2018 | 1059 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3827 | 0.240 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2022 | 28 | 0.240 |
Why?
|
| Cell Movement | 6 | 2013 | 872 | 0.230 |
Why?
|
| Phosphorylation | 6 | 2021 | 1580 | 0.230 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2407 | 0.230 |
Why?
|
| Inflammation Mediators | 1 | 2006 | 229 | 0.220 |
Why?
|
| Ligands | 2 | 2018 | 486 | 0.220 |
Why?
|
| Signal Transduction | 10 | 2021 | 4697 | 0.210 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 160 | 0.210 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1001 | 0.200 |
Why?
|
| Peptides | 5 | 2022 | 708 | 0.200 |
Why?
|
| Phosphotyrosine | 2 | 2003 | 30 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2008 | 646 | 0.200 |
Why?
|
| Animals | 19 | 2024 | 33981 | 0.200 |
Why?
|
| Inflammation | 2 | 2010 | 1478 | 0.190 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 140 | 0.190 |
Why?
|
| Integrin beta1 | 3 | 1998 | 53 | 0.190 |
Why?
|
| Ischemia | 2 | 2016 | 358 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 72 | 0.180 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 73 | 0.180 |
Why?
|
| Jurkat Cells | 9 | 2013 | 85 | 0.180 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2001 | 3 | 0.180 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 29 | 0.180 |
Why?
|
| Asthma | 2 | 2008 | 909 | 0.180 |
Why?
|
| Models, Immunological | 1 | 2001 | 36 | 0.180 |
Why?
|
| CD28 Antigens | 2 | 1998 | 76 | 0.170 |
Why?
|
| Botulinum Toxins | 2 | 2003 | 112 | 0.170 |
Why?
|
| THP-1 Cells | 1 | 2021 | 21 | 0.170 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 420 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 120 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2006 | 715 | 0.150 |
Why?
|
| Lipoproteins, LDL | 2 | 2024 | 119 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 132 | 0.150 |
Why?
|
| Leukocyte Common Antigens | 1 | 1999 | 84 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2001 | 1006 | 0.150 |
Why?
|
| Ribose | 1 | 1998 | 12 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 2 | 1998 | 111 | 0.140 |
Why?
|
| Adenosine Diphosphate | 1 | 1998 | 50 | 0.140 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 20 | 0.140 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3497 | 0.140 |
Why?
|
| Molecular Conformation | 1 | 2018 | 96 | 0.140 |
Why?
|
| CHO Cells | 6 | 2003 | 151 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 1998 | 158 | 0.130 |
Why?
|
| Cricetinae | 6 | 2003 | 362 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 622 | 0.130 |
Why?
|
| Fibronectins | 3 | 2009 | 100 | 0.130 |
Why?
|
| Humans | 33 | 2024 | 130854 | 0.130 |
Why?
|
| Antibodies | 1 | 1998 | 320 | 0.130 |
Why?
|
| Liposomes | 1 | 2018 | 196 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 716 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 267 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 554 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2024 | 953 | 0.120 |
Why?
|
| Epoprostenol | 1 | 2016 | 35 | 0.120 |
Why?
|
| Protein Subunits | 2 | 2014 | 160 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 82 | 0.110 |
Why?
|
| Melanoma | 1 | 2022 | 925 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 195 | 0.110 |
Why?
|
| Cytoplasm | 4 | 2003 | 253 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 665 | 0.100 |
Why?
|
| Cell Line | 5 | 2016 | 2580 | 0.100 |
Why?
|
| Integrin alpha4 | 4 | 2003 | 12 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 220 | 0.100 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2013 | 31 | 0.100 |
Why?
|
| Solubility | 2 | 2006 | 117 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 501 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 197 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 382 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 3 | 2004 | 225 | 0.090 |
Why?
|
| Integrin alpha2beta1 | 1 | 2012 | 8 | 0.090 |
Why?
|
| Adherens Junctions | 1 | 2012 | 17 | 0.090 |
Why?
|
| Kinetics | 2 | 2006 | 1089 | 0.090 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2002 | 13 | 0.090 |
Why?
|
| src Homology Domains | 2 | 2002 | 35 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 667 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2006 | 812 | 0.090 |
Why?
|
| Cell Division | 3 | 2003 | 721 | 0.090 |
Why?
|
| Cadherins | 1 | 2012 | 184 | 0.090 |
Why?
|
| ADP Ribose Transferases | 2 | 2003 | 20 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2003 | 44 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2002 | 584 | 0.080 |
Why?
|
| Thiophenes | 1 | 2010 | 68 | 0.080 |
Why?
|
| Binding Sites | 4 | 2006 | 1149 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 243 | 0.080 |
Why?
|
| Mice | 5 | 2022 | 18267 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3836 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2010 | 730 | 0.080 |
Why?
|
| Urea | 1 | 2010 | 219 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 471 | 0.080 |
Why?
|
| G(M1) Ganglioside | 1 | 2009 | 10 | 0.070 |
Why?
|
| Actins | 2 | 2003 | 316 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 60 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 300 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 715 | 0.070 |
Why?
|
| Swine | 1 | 2011 | 1187 | 0.070 |
Why?
|
| CD18 Antigens | 2 | 1998 | 42 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4682 | 0.060 |
Why?
|
| Antibody Specificity | 2 | 1998 | 164 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 1324 | 0.060 |
Why?
|
| Drug Design | 1 | 2008 | 162 | 0.060 |
Why?
|
| Dendritic Cells | 2 | 2001 | 436 | 0.060 |
Why?
|
| Myocardium | 1 | 2011 | 863 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2006 | 20 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 122 | 0.060 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2003 | 25 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2002 | 111 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2906 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 694 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2006 | 328 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2006 | 312 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2003 | 582 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 984 | 0.050 |
Why?
|
| Cytokines | 2 | 2022 | 1336 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2004 | 131 | 0.050 |
Why?
|
| Cell Surface Extensions | 1 | 2003 | 6 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2003 | 7 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2003 | 16 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 81 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 13 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2022 | 114 | 0.050 |
Why?
|
| Antigens | 1 | 2022 | 104 | 0.050 |
Why?
|
| Nickel | 1 | 2002 | 19 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2002 | 54 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2002 | 40 | 0.050 |
Why?
|
| Ionomycin | 2 | 2000 | 14 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 64 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2000 | 58 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 2001 | 15 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2001 | 11 | 0.040 |
Why?
|
| Base Sequence | 1 | 2006 | 2764 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2001 | 28 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 148 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2001 | 51 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 623 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 145 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 143 | 0.040 |
Why?
|
| Reference Values | 2 | 1999 | 679 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 112 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 2000 | 17 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1420 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 391 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 561 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 272 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 1997 | 145 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2612 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1996 | 92 | 0.040 |
Why?
|
| Weightlessness | 1 | 2001 | 83 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 790 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 750 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 464 | 0.040 |
Why?
|
| Cytoskeleton | 3 | 2009 | 166 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 108 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 179 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2002 | 902 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1618 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 57 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 1998 | 43 | 0.040 |
Why?
|
| Interphase | 1 | 1998 | 37 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 36 | 0.040 |
Why?
|
| Paxillin | 3 | 2003 | 13 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 53 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 600 | 0.030 |
Why?
|
| Cell Separation | 1 | 1998 | 220 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1998 | 131 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 701 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1844 | 0.030 |
Why?
|
| Amino Acid Substitution | 3 | 2003 | 407 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12913 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2000 | 982 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1998 | 348 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2022 | 755 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 601 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1998 | 655 | 0.030 |
Why?
|
| Iloprost | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2016 | 22 | 0.030 |
Why?
|
| Reperfusion | 1 | 2016 | 26 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 356 | 0.030 |
Why?
|
| Running | 1 | 2016 | 32 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 203 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 364 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 301 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 257 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 589 | 0.030 |
Why?
|
| Epitopes | 1 | 1996 | 322 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 199 | 0.030 |
Why?
|
| Male | 1 | 2021 | 64763 | 0.030 |
Why?
|
| Integrin alpha5beta1 | 1 | 2013 | 4 | 0.020 |
Why?
|
| CD11a Antigen | 1 | 2013 | 11 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 809 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 34 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1399 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 498 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3727 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 12 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1234 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 6217 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2013 | 152 | 0.020 |
Why?
|
| Transfection | 2 | 2003 | 963 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 305 | 0.020 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Transcription Factors | 2 | 1999 | 2454 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 632 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 1230 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 62 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2010 | 221 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4715 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2000 | 771 | 0.020 |
Why?
|
| Mannosides | 1 | 2004 | 2 | 0.010 |
Why?
|
| Mannose | 1 | 2004 | 25 | 0.010 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2004 | 51 | 0.010 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 24 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 75 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 36 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 303 | 0.010 |
Why?
|
| Talin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Isoleucine | 1 | 2001 | 24 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2001 | 14 | 0.010 |
Why?
|
| Filamins | 1 | 2001 | 26 | 0.010 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2001 | 6 | 0.010 |
Why?
|
| Valine | 1 | 2001 | 110 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 22 | 0.010 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2001 | 53 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2001 | 119 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 450 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 97 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2001 | 92 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2001 | 124 | 0.010 |
Why?
|
| Fusion Regulatory Protein-1 | 1 | 2000 | 3 | 0.010 |
Why?
|
| Ionophores | 1 | 2000 | 9 | 0.010 |
Why?
|
| Microcomputers | 1 | 2000 | 11 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 17 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 1999 | 1977 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 188 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 277 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 1999 | 65 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 688 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 144 | 0.010 |
Why?
|
| Microscopy | 1 | 2000 | 118 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1125 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1998 | 12 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1998 | 150 | 0.010 |
Why?
|
| Video Recording | 1 | 2000 | 207 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 1998 | 10 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1998 | 51 | 0.010 |
Why?
|
| Light | 1 | 1998 | 171 | 0.010 |
Why?
|
| Muromonab-CD3 | 1 | 1996 | 7 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 1996 | 39 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1998 | 813 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1996 | 442 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 4482 | 0.000 |
Why?
|
| Female | 1 | 2012 | 70550 | 0.000 |
Why?
|